Lukas Heger

Dr. Lukas Heger

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2016 in Science Immunology
Verified
Journal Article
Closed access
PDF file
GHGordon F. Heidkamp
Gordon F. Heidkamp
JSJil Sander
Jil Sander
CLChristian Lehmann
Christian Lehmann
LHLukas Heger
Lukas Heger
NENathalie Eissing
Nathalie Eissing
DDDiana Dudziak
Diana Dudziak
Transcriptional identity of human dendritic cell subsets is mainly dictated by ontogeny rather than by signals derived from the cells’ final tissue microenvironment.

27 April 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LHLukas Heger
Lukas Heger
SBSilke Balk
Silke Balk
JLJennifer J. Lühr
Jennifer J. Lühr
GHGordon F. Heidkamp
Gordon F. Heidkamp
CLChristian Lehmann
Christian Lehmann
DDDiana Dudziak
Diana Dudziak
Dendritic cells (DCs) are major players for the induction of immune responses. Apart from plasmacytoid DCs (pDCs), human DCs can be categorized into two types of conventional DCs: CD141+ DCs (cDC1) and CD1c+ DCs (cDC2). Defining uniquely expressed surface markers on human immune cells is not only important for the identification of DC subpopulations but also a prerequisite for harnessing the DC subset-specific potential in immunomodulatory approaches, such as antibody-mediated antigen targeting. Although others identified CLEC9A as a specific endocytic receptor for CD141+ DCs, such a receptor for CD1c+ DCs has not been discovered, yet. By performing transcriptomic and flow cytometric analyses on human DC subpopulations from different lymphohematopoietic tissues, we identified CLEC10A (CD301, macrophage galactose-type C-type lectin) as a specific marker for human CD1c+ DCs. We further demonstrate that CLEC10A rapidly internalizes into human CD1c+ DCs upon binding of a monoclonal antibody directed against CLEC10A. The binding of a CLEC10A-specific bivalent ligand (the MUC-1 peptide glycosylated with N-acetylgalactosamine) is limited to CD1c+ DCs and enhances the cytokine secretion (namely TNFα, IL-8, and IL-10) induced by TLR 7/8 stimulation. Thus, CLEC10A represents not only a candidate to better define CD1c+ DCs—due to its high endocytic potential—CLEC10A also exhibits an interesting candidate receptor for future antigen-targeting approaches.

28 March 2016 in Vaccines
Verified
Journal Article
Open access
PDF file
CLChristian Lehmann
Christian Lehmann
LHLukas Heger
Lukas Heger
GHGordon F. Heidkamp
Gordon F. Heidkamp
ABAnna Baranska
Anna Baranska
JLJennifer J. Lühr
Jennifer J. Lühr
DDDiana Dudziak
Diana Dudziak
Dendritic cells (DCs) are the most potent professional antigen presenting cells and are therefore indispensable for the control of immunity. The technique of antibody mediated antigen targeting to DC subsets has been the basis of intense research for more than a decade. Many murine studies have utilized this approach of antigen delivery to various kinds of endocytic receptors of DCs both in vitro and in vivo. Today, it is widely accepted that different DC subsets are important for the induction of select immune responses. Nevertheless, many questions still remain to be answered, such as the actual influence of the targeted receptor on the initiation of the immune response to the delivered antigen. Further efforts to better understand the induction of antigen-specific immune responses will support the transfer of this knowledge into novel treatment strategies for human diseases. In this review, we will discuss the state-of-the-art aspects of the basic principles of antibody mediated antigen targeting approaches. A table will also provide a broad overview of the latest studies using antigen targeting including addressed DC subset, targeted receptors, outcome, and applied coupling techniques.

7 April 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CLChristian Lehmann
Christian Lehmann
ABAnna Baranska
Anna Baranska
GHGordon F. Heidkamp
Gordon F. Heidkamp
LHLukas Heger
Lukas Heger
KNKirsten Neubert
Kirsten Neubert
DDDiana Dudziak
Diana Dudziak
Dendritic cells (DCs) are efficient antigen-presenting cells equipped with various cell surface receptors for the direct or indirect recognition of pathogenic microorganisms. Interestingly, not much is known about the specific expression pattern and function of the individual activating and inhibitory Fcγ receptors (FcγRs) on splenic DC subsets in vivo and how they contribute to the initiation of T cell responses. By targeting antigens to select activating and the inhibitory FcγR in vivo, we show that antigen uptake under steady-state conditions results in a short-term expansion of antigen-specific T cells, whereas under inflammatory conditions especially, the activating FcγRIV is able to induce superior CD4+ and CD8+ T cell responses. Of note, this effect was independent of FcγR intrinsic activating signaling pathways. Moreover, despite the expression of FcγRIV on both conventional splenic DC subsets, the induction of CD8+ T cell responses was largely dependent on CD11c+CD8+ DCs, whereas CD11c+CD8− DCs were critical for priming CD4+ T cell responses.

15 June 2014 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
KNKirsten Neubert
Kirsten Neubert
CLChristian Lehmann
Christian Lehmann
LHLukas Heger
Lukas Heger
ABAnna Baranska
Anna Baranska
ASAnna Maria Staedtler
Anna Maria Staedtler
DDDiana Dudziak
Diana Dudziak
Dendritic cells (DCs) are central modulators of immune responses and, therefore, interesting target cells for the induction of antitumor immune responses. Ag delivery to select DC subpopulations via targeting Abs to DC inhibitory receptor 2 (DCIR2, clone 33D1) or to DEC205 was shown to direct Ags specifically to CD11c+CD8− or CD11c+CD8+ DCs, respectively, in vivo. In contrast to the increasing knowledge about the induction of immune responses by efficiently cross-presenting CD11c+CD8+ DCs, little is known about the functional role of Ag-presenting CD11c+CD8− DCs with regard to the initiation of protective immune responses. In this study, we demonstrate that Ag targeting to the CD11c+CD8− DC subpopulation in the presence of stimulating anti-CD40 Ab and TLR3 ligand polyinosinic-polycytidylic acid induces protective responses against rapidly growing tumor cells in naive animals under preventive and therapeutic treatment regimens in vivo. Of note, this immunization protocol induced a mixed Th1/Th2-driven immune response, irrespective of which DC subpopulation initially presented the Ag. Our results provide important information about the role of CD11c+CD8− DCs, which have been considered to be less efficient at cross-presenting Ags, in the induction of protective antitumor immune responses.

1 January 2019
Verified
Book Chapter
Closed access
LALukas Amon
Lukas Amon
CLChristian H K Lehmann
Christian H K Lehmann
ABAnna Baranska
Anna Baranska
JSJanina Schoen
Janina Schoen
LHLukas Heger
Lukas Heger
DDDiana Dudziak
Diana Dudziak